Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sequence-dependent cross-resistance of combined radiotherapy plus BRAF<sup>V600E</sup> inhibition in melanoma.

European journal of cancer (Oxford, England : 1990)·2019

Same author

[The role of focal adhesions in Ewing's sarcoma].

Der Pathologe·2017

Same author

MRD response in a refractory paediatric T-ALL patient through anti-programmed cell death 1 (PD-1) Ab treatment associated with induction of fatal GvHD.

Bone marrow transplantation·2017

Same author

EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma.

Oncogene·2016

Same author

Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.

Oncogene·2016

Same author

Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment.

British journal of cancer·2013

Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022

Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022

Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022

Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022

Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022

Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 23, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

[Functional genomics of Ewing sarcoma].

T G P Grünewald¹

¹Max-Eder Nachwuchsgruppe für Pädiatrische Sarkombiologie, Pathologisches Institut, Medizinische Fakultät, LMU München, Thalkirchner Str. 36, 80337, München, Deutschland. thomas.gruenewald@med.uni-muenchen.de.

|August 30, 2017

Summary

This summary is machine-generated.

New therapeutic strategies are needed for Ewing sarcoma, a rare childhood cancer. Researchers are exploring EWSR1-ETS target genes as potential therapeutic targets and biomarkers for minimal residual disease.

Keywords:

EWSR1-ETS Ewing sarcoma Functional genomics Genetic epidemiology Liquid biopsy

More Related Videos

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Related Experiment Videos

Last Updated: Feb 23, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Area of Science:

Pediatric Oncology
Molecular Biology
Cancer Genomics

Background:

Ewing sarcoma is an aggressive pediatric cancer with significant treatment toxicities.
Current therapies face challenges due to the nature of EWSR1-ETS fusion oncoproteins.
There is a critical need for more effective and less toxic treatment options.

Purpose of the Study:

To review therapeutic strategies targeting EWSR1-ETS fusion genes in Ewing sarcoma.
To explore novel surrogate targets and biomarkers for Ewing sarcoma.
To discuss the medical relevance of recent findings in Ewing sarcoma research.

Main Methods:

Review of functional genomics studies.
Analysis of EWSR1-ETS target gene expression.
Investigation of circulating free DNA and exosomal mRNA markers.

Main Results:

Identification of EWSR1-ETS target genes as potential therapeutic surrogates.
Mechanistic insights into Ewing sarcoma incidence in Europeans.
Emerging role of cell-free DNA and exosomal mRNA in minimal residual disease detection.

Conclusions:

EWSR1-ETS target genes offer promising avenues for novel (immuno-)therapies.
Biomarkers for minimal residual disease are under active investigation.
Further research holds potential for improved Ewing sarcoma management.